Learn More
Medchemexpress LLC Avotaciclib (trihydrochloride) | 1983984-01-5 | 99.6% | 390.66 | 1 MG

Supplier: Medchemexpress LLC HY137432A1MG
Avotaciclib trihydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. It can inhibit the proliferation and induce apoptosis of tumor cells. This product is used in the research of cancers such as pancreatic cancer and lung cancer.
- Inhibits cell proliferation and promotes apoptosis in radiotherapy-resistant non-small cell lung cancer cell lines.
- Demonstrates enhanced efficacy when used in combination with certain other compounds.
- Applicable in cancer research, including studies on pancreatic and lung cancer.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.